AIFM2 and hepatocellular carcinoma: Watabe et al. reported that 4-HNE accumulation in hepatocellular carcinoma is regulated by the differential metabolic activity of 4-HNE through SMARCA4, regardless of the expression of GPX4, FSP1, or GCH1 [22].